Whole grain metabolite 3,5-dihydroxybenzoic acid is a beneficial nutritional molecule with the feature of a double-edged sword in human health: a critical review and dietary considerations

代谢物 全谷物 生物 受体 人类健康 健康福利 癌变 药理学 癌症 生物化学 食品科学 医学 遗传学 传统医学 环境卫生
作者
W. C. Wagner,Katarzyna Sobierajska,Łukasz Pułaski,Anna Stasiak,Wojciech M. Ciszewski
出处
期刊:Critical Reviews in Food Science and Nutrition [Taylor & Francis]
卷期号:64 (24): 8786-8804 被引量:10
标识
DOI:10.1080/10408398.2023.2203762
摘要

Nonprocessed foodstuffs of plant origin, especially whole-grain cereals, are considered to be health-promoting components of the human diet. While most of their well-studied effects derive from their high fiber content and low glycemic index, the presence of underrated phenolic phytonutrients has recently been brought to the attention of nutritionists. In this review, we report and discuss findings on the sources and bioactivities of 3,5-dihydroxybenzoic acid (3,5-DHBA), which is both a direct dietary component (found, e.g., in apples) and, more importantly, a crucial metabolite of whole-grain cereal-derived alkylresorcinols (ARs). 3,5-DHBA is a recently described exogenous agonist of the HCAR1/GPR81 receptor. We concentrate on the HCAR1-mediated effects of 3,5-DHBA in the nervous system, on the maintenance of cell stemness, regulation of carcinogenesis, and response to anticancer therapy. Unexpectedly, malignant tumors take advantage of HCAR1 expression to sense 3,5-DHBA to support their growth. Thus, there is an urgent need to fully identify the role of whole-grain-derived 3,5-DHBA during anticancer therapy and its contribution in the regulation of vital organs of the body via its specific HCAR1 receptor. We discuss here in detail the possible consequences of the modulatory capabilities of 3,5-DHBA in physiological and pathological conditions in humans.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
慕青应助小荣同学采纳,获得10
1秒前
抹茶味的奶酥完成签到,获得积分10
2秒前
深情隶完成签到,获得积分10
3秒前
bai完成签到,获得积分10
5秒前
hingyao发布了新的文献求助10
6秒前
N7发布了新的文献求助10
6秒前
无极微光应助长情天川采纳,获得20
7秒前
molihuakai应助科研通管家采纳,获得10
7秒前
7秒前
Jasper应助科研通管家采纳,获得10
7秒前
LZZ完成签到,获得积分10
7秒前
CFD应助科研通管家采纳,获得10
7秒前
dandna完成签到 ,获得积分10
7秒前
8秒前
小二郎应助科研通管家采纳,获得10
8秒前
9秒前
科研小趴菜完成签到,获得积分10
9秒前
wei完成签到,获得积分10
10秒前
慕青应助草莓小蛋糕采纳,获得10
11秒前
无极微光应助Uu采纳,获得20
11秒前
Gleaming完成签到,获得积分10
12秒前
JamesPei应助何日寻采纳,获得10
13秒前
科研通AI6.2应助小白先生采纳,获得20
14秒前
852应助hingyao采纳,获得10
15秒前
xmhxpz发布了新的文献求助10
18秒前
春桑早点睡完成签到,获得积分10
19秒前
Jaysmith001应助jjjj采纳,获得80
19秒前
21秒前
panbl451245完成签到,获得积分20
21秒前
Lucas应助花花采纳,获得10
24秒前
24秒前
Ning关注了科研通微信公众号
25秒前
25秒前
花盈满袖完成签到,获得积分10
25秒前
ZZzz完成签到,获得积分10
27秒前
28秒前
Anna完成签到 ,获得积分10
29秒前
明明发布了新的文献求助10
29秒前
lmy02发布了新的文献求助10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6955240
求助须知:如何正确求助?哪些是违规求助? 8638851
关于积分的说明 18319535
捐赠科研通 6400180
什么是DOI,文献DOI怎么找? 3083540
关于科研通互助平台的介绍 2130001
邀请新用户注册赠送积分活动 2060361